Delivery Order SPE2DB22D3401-SPE2DB25FT5YD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Benlysta 200 mg/ml syringes, with a ceiling value of $6,152.80 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with a completion date of September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,330.68 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units. The contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price procurement executed without set-aside provisions, indicating open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its extensive federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/mL syringes valued at $6,152.80, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $3,076.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml syringes, with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $3,076.40. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,777.72 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. This contract, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. The award was made competitively and represents a specific fulfillment requirement under AmerisourceBergen's larger federal contract vehicle supporting military healthcare procurement....
- The Defense Logistics Agency awarded a $18,147.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.40 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml syringes. The contract, issued on August 11, 2025, carries a firm fixed price and is scheduled for completion by September 2, 2025. This is a competitive award with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,308.18 for 400 mg Benlysta vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5YDDelivery Order
The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes under a firm fixed price contract. The award, issued on September 2, 2025, with a completion date of September 23, 2025, represents a non-set-aside competitive award to supply this immunosuppressive medication to support federal healthcare requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement allows AmerisourceBergen to serve customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a critical vendor within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/2/25 |